nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB3—connective tissue—systemic scleroderma	0.0118	0.0671	CbGeAlD
Ixabepilone—TUBB3—digestive system—systemic scleroderma	0.00849	0.0484	CbGeAlD
Ixabepilone—TUBB4A—connective tissue—systemic scleroderma	0.00715	0.0408	CbGeAlD
Ixabepilone—TUBB3—lung—systemic scleroderma	0.00709	0.0405	CbGeAlD
Ixabepilone—TUBB2B—connective tissue—systemic scleroderma	0.00691	0.0395	CbGeAlD
Ixabepilone—TUBB2A—connective tissue—systemic scleroderma	0.00651	0.0371	CbGeAlD
Ixabepilone—TUBB4A—skin of body—systemic scleroderma	0.00646	0.0369	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—systemic scleroderma	0.00598	0.0342	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00595	0.034	CbGeAlD
Ixabepilone—TUBB2A—skin of body—systemic scleroderma	0.00587	0.0335	CbGeAlD
Ixabepilone—TUBB6—smooth muscle tissue—systemic scleroderma	0.00587	0.0335	CbGeAlD
Ixabepilone—TUBB6—skin of body—systemic scleroderma	0.00579	0.0331	CbGeAlD
Ixabepilone—TUBB4B—connective tissue—systemic scleroderma	0.00558	0.0318	CbGeAlD
Ixabepilone—TUBB4A—digestive system—systemic scleroderma	0.00517	0.0295	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—systemic scleroderma	0.0051	0.0291	CbGeAlD
Ixabepilone—TUBB4B—skin of body—systemic scleroderma	0.00504	0.0287	CbGeAlD
Ixabepilone—TUBB2B—digestive system—systemic scleroderma	0.00499	0.0285	CbGeAlD
Ixabepilone—TUBB4A—tendon—systemic scleroderma	0.00492	0.0281	CbGeAlD
Ixabepilone—TUBB2B—tendon—systemic scleroderma	0.00475	0.0271	CbGeAlD
Ixabepilone—TUBB2A—digestive system—systemic scleroderma	0.0047	0.0268	CbGeAlD
Ixabepilone—TUBB6—digestive system—systemic scleroderma	0.00463	0.0265	CbGeAlD
Ixabepilone—TUBB—tendon—systemic scleroderma	0.0045	0.0257	CbGeAlD
Ixabepilone—TUBB2A—tendon—systemic scleroderma	0.00447	0.0255	CbGeAlD
Ixabepilone—TUBB6—tendon—systemic scleroderma	0.00441	0.0252	CbGeAlD
Ixabepilone—TUBB4A—lung—systemic scleroderma	0.00431	0.0246	CbGeAlD
Ixabepilone—TUBB2B—lung—systemic scleroderma	0.00417	0.0238	CbGeAlD
Ixabepilone—TUBB4B—digestive system—systemic scleroderma	0.00403	0.023	CbGeAlD
Ixabepilone—TUBB—lung—systemic scleroderma	0.00395	0.0225	CbGeAlD
Ixabepilone—TUBB2A—lung—systemic scleroderma	0.00392	0.0224	CbGeAlD
Ixabepilone—TUBB6—lung—systemic scleroderma	0.00387	0.0221	CbGeAlD
Ixabepilone—TUBB4B—tendon—systemic scleroderma	0.00383	0.0219	CbGeAlD
Ixabepilone—TUBB4B—lung—systemic scleroderma	0.00336	0.0192	CbGeAlD
Ixabepilone—CYP3A4—digestive system—systemic scleroderma	0.00166	0.00945	CbGeAlD
Ixabepilone—Loss of consciousness—Lisinopril—systemic scleroderma	0.000958	0.00116	CcSEcCtD
Ixabepilone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000955	0.00116	CcSEcCtD
Ixabepilone—Cough—Lisinopril—systemic scleroderma	0.000951	0.00115	CcSEcCtD
Ixabepilone—Muscular weakness—Prednisone—systemic scleroderma	0.000948	0.00115	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000947	0.00115	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000943	0.00114	CcSEcCtD
Ixabepilone—Anorexia—Mycophenolic acid—systemic scleroderma	0.000942	0.00114	CcSEcCtD
Ixabepilone—Insomnia—Leflunomide—systemic scleroderma	0.000937	0.00114	CcSEcCtD
Ixabepilone—Paraesthesia—Leflunomide—systemic scleroderma	0.00093	0.00113	CcSEcCtD
Ixabepilone—Chest pain—Lisinopril—systemic scleroderma	0.000928	0.00113	CcSEcCtD
Ixabepilone—Myalgia—Lisinopril—systemic scleroderma	0.000928	0.00113	CcSEcCtD
Ixabepilone—Arthralgia—Lisinopril—systemic scleroderma	0.000928	0.00113	CcSEcCtD
Ixabepilone—Dyspnoea—Leflunomide—systemic scleroderma	0.000923	0.00112	CcSEcCtD
Ixabepilone—Hypotension—Mycophenolic acid—systemic scleroderma	0.000923	0.00112	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000922	0.00112	CcSEcCtD
Ixabepilone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000918	0.00111	CcSEcCtD
Ixabepilone—Lethargy—Methotrexate—systemic scleroderma	0.000917	0.00111	CcSEcCtD
Ixabepilone—Vomiting—Mometasone—systemic scleroderma	0.00091	0.0011	CcSEcCtD
Ixabepilone—Rash—Mometasone—systemic scleroderma	0.000902	0.00109	CcSEcCtD
Ixabepilone—Asthenia—Captopril—systemic scleroderma	0.000901	0.00109	CcSEcCtD
Ixabepilone—Dermatitis—Mometasone—systemic scleroderma	0.000901	0.00109	CcSEcCtD
Ixabepilone—Decreased appetite—Leflunomide—systemic scleroderma	0.0009	0.00109	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.0009	0.00109	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000897	0.00109	CcSEcCtD
Ixabepilone—Headache—Mometasone—systemic scleroderma	0.000896	0.00109	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000894	0.00108	CcSEcCtD
Ixabepilone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000893	0.00108	CcSEcCtD
Ixabepilone—Fatigue—Leflunomide—systemic scleroderma	0.000893	0.00108	CcSEcCtD
Ixabepilone—Oedema—Lisinopril—systemic scleroderma	0.00089	0.00108	CcSEcCtD
Ixabepilone—Pruritus—Captopril—systemic scleroderma	0.000889	0.00108	CcSEcCtD
Ixabepilone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000887	0.00108	CcSEcCtD
Ixabepilone—Constipation—Leflunomide—systemic scleroderma	0.000886	0.00107	CcSEcCtD
Ixabepilone—Pain—Leflunomide—systemic scleroderma	0.000886	0.00107	CcSEcCtD
Ixabepilone—Infection—Lisinopril—systemic scleroderma	0.000884	0.00107	CcSEcCtD
Ixabepilone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000883	0.00107	CcSEcCtD
Ixabepilone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000881	0.00107	CcSEcCtD
Ixabepilone—Shock—Lisinopril—systemic scleroderma	0.000875	0.00106	CcSEcCtD
Ixabepilone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000871	0.00106	CcSEcCtD
Ixabepilone—Neutropenia—Prednisone—systemic scleroderma	0.000869	0.00105	CcSEcCtD
Ixabepilone—Abdominal pain—Azathioprine—systemic scleroderma	0.000867	0.00105	CcSEcCtD
Ixabepilone—Body temperature increased—Azathioprine—systemic scleroderma	0.000867	0.00105	CcSEcCtD
Ixabepilone—Skin disorder—Lisinopril—systemic scleroderma	0.000864	0.00105	CcSEcCtD
Ixabepilone—Diarrhoea—Captopril—systemic scleroderma	0.00086	0.00104	CcSEcCtD
Ixabepilone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000859	0.00104	CcSEcCtD
Ixabepilone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000857	0.00104	CcSEcCtD
Ixabepilone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000855	0.00104	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000853	0.00103	CcSEcCtD
Ixabepilone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000852	0.00103	CcSEcCtD
Ixabepilone—Nausea—Mometasone—systemic scleroderma	0.00085	0.00103	CcSEcCtD
Ixabepilone—Anorexia—Lisinopril—systemic scleroderma	0.000848	0.00103	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000847	0.00103	CcSEcCtD
Ixabepilone—Constipation—Mycophenolic acid—systemic scleroderma	0.000845	0.00102	CcSEcCtD
Ixabepilone—Pain—Mycophenolic acid—systemic scleroderma	0.000845	0.00102	CcSEcCtD
Ixabepilone—Weight decreased—Prednisone—systemic scleroderma	0.000841	0.00102	CcSEcCtD
Ixabepilone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00084	0.00102	CcSEcCtD
Ixabepilone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000834	0.00101	CcSEcCtD
Ixabepilone—Hypotension—Lisinopril—systemic scleroderma	0.000831	0.00101	CcSEcCtD
Ixabepilone—Dizziness—Captopril—systemic scleroderma	0.000831	0.00101	CcSEcCtD
Ixabepilone—Abdominal pain—Leflunomide—systemic scleroderma	0.000819	0.000992	CcSEcCtD
Ixabepilone—Body temperature increased—Leflunomide—systemic scleroderma	0.000819	0.000992	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000817	0.00099	CcSEcCtD
Ixabepilone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000813	0.000986	CcSEcCtD
Ixabepilone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000813	0.000986	CcSEcCtD
Ixabepilone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000813	0.000986	CcSEcCtD
Ixabepilone—Myocardial infarction—Prednisone—systemic scleroderma	0.000812	0.000985	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000812	0.000985	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000811	0.000983	CcSEcCtD
Ixabepilone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000808	0.000979	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000808	0.000979	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000808	0.000979	CcSEcCtD
Ixabepilone—Insomnia—Lisinopril—systemic scleroderma	0.000805	0.000976	CcSEcCtD
Ixabepilone—Paraesthesia—Lisinopril—systemic scleroderma	0.000799	0.000969	CcSEcCtD
Ixabepilone—Vomiting—Captopril—systemic scleroderma	0.000799	0.000969	CcSEcCtD
Ixabepilone—Dyspnoea—Lisinopril—systemic scleroderma	0.000793	0.000962	CcSEcCtD
Ixabepilone—Rash—Captopril—systemic scleroderma	0.000792	0.00096	CcSEcCtD
Ixabepilone—Dermatitis—Captopril—systemic scleroderma	0.000791	0.00096	CcSEcCtD
Ixabepilone—Headache—Captopril—systemic scleroderma	0.000787	0.000954	CcSEcCtD
Ixabepilone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000781	0.000947	CcSEcCtD
Ixabepilone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000781	0.000947	CcSEcCtD
Ixabepilone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00078	0.000945	CcSEcCtD
Ixabepilone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000775	0.000939	CcSEcCtD
Ixabepilone—Decreased appetite—Lisinopril—systemic scleroderma	0.000773	0.000938	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000768	0.000931	CcSEcCtD
Ixabepilone—Fatigue—Lisinopril—systemic scleroderma	0.000767	0.00093	CcSEcCtD
Ixabepilone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000767	0.00093	CcSEcCtD
Ixabepilone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000765	0.000927	CcSEcCtD
Ixabepilone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000763	0.000925	CcSEcCtD
Ixabepilone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000763	0.000925	CcSEcCtD
Ixabepilone—Constipation—Lisinopril—systemic scleroderma	0.000761	0.000923	CcSEcCtD
Ixabepilone—Pain—Lisinopril—systemic scleroderma	0.000761	0.000923	CcSEcCtD
Ixabepilone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000918	CcSEcCtD
Ixabepilone—Diarrhoea—Azathioprine—systemic scleroderma	0.00075	0.00091	CcSEcCtD
Ixabepilone—Haemoglobin—Prednisone—systemic scleroderma	0.000748	0.000906	CcSEcCtD
Ixabepilone—Nausea—Captopril—systemic scleroderma	0.000746	0.000905	CcSEcCtD
Ixabepilone—Haemorrhage—Prednisone—systemic scleroderma	0.000744	0.000902	CcSEcCtD
Ixabepilone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000743	0.000901	CcSEcCtD
Ixabepilone—Asthenia—Leflunomide—systemic scleroderma	0.000743	0.000901	CcSEcCtD
Ixabepilone—Pancytopenia—Methotrexate—systemic scleroderma	0.000738	0.000894	CcSEcCtD
Ixabepilone—Pruritus—Leflunomide—systemic scleroderma	0.000733	0.000888	CcSEcCtD
Ixabepilone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000731	0.000886	CcSEcCtD
Ixabepilone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000728	0.000883	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000728	0.000882	CcSEcCtD
Ixabepilone—Neutropenia—Methotrexate—systemic scleroderma	0.000726	0.00088	CcSEcCtD
Ixabepilone—Dizziness—Azathioprine—systemic scleroderma	0.000725	0.000879	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000722	0.000875	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00071	0.000861	CcSEcCtD
Ixabepilone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000709	0.000859	CcSEcCtD
Ixabepilone—Diarrhoea—Leflunomide—systemic scleroderma	0.000709	0.000859	CcSEcCtD
Ixabepilone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000705	0.000855	CcSEcCtD
Ixabepilone—Body temperature increased—Lisinopril—systemic scleroderma	0.000703	0.000853	CcSEcCtD
Ixabepilone—Abdominal pain—Lisinopril—systemic scleroderma	0.000703	0.000853	CcSEcCtD
Ixabepilone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.0007	0.000849	CcSEcCtD
Ixabepilone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000699	0.000847	CcSEcCtD
Ixabepilone—Vomiting—Azathioprine—systemic scleroderma	0.000697	0.000845	CcSEcCtD
Ixabepilone—Pneumonia—Methotrexate—systemic scleroderma	0.000696	0.000844	CcSEcCtD
Ixabepilone—Eye disorder—Prednisone—systemic scleroderma	0.000695	0.000843	CcSEcCtD
Ixabepilone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000843	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—systemic scleroderma	0.000692	0.00084	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—systemic scleroderma	0.000692	0.00084	CcSEcCtD
Ixabepilone—Rash—Azathioprine—systemic scleroderma	0.000691	0.000838	CcSEcCtD
Ixabepilone—Dermatitis—Azathioprine—systemic scleroderma	0.000691	0.000837	CcSEcCtD
Ixabepilone—Headache—Azathioprine—systemic scleroderma	0.000687	0.000833	CcSEcCtD
Ixabepilone—Dizziness—Leflunomide—systemic scleroderma	0.000685	0.00083	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—systemic scleroderma	0.000681	0.000825	CcSEcCtD
Ixabepilone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000678	0.000822	CcSEcCtD
Ixabepilone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000676	0.000819	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—systemic scleroderma	0.000675	0.000818	CcSEcCtD
Ixabepilone—Angiopathy—Prednisone—systemic scleroderma	0.000675	0.000818	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000673	0.000816	CcSEcCtD
Ixabepilone—Immune system disorder—Prednisone—systemic scleroderma	0.000672	0.000815	CcSEcCtD
Ixabepilone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000808	CcSEcCtD
Ixabepilone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000808	CcSEcCtD
Ixabepilone—Vomiting—Leflunomide—systemic scleroderma	0.000658	0.000798	CcSEcCtD
Ixabepilone—Alopecia—Prednisone—systemic scleroderma	0.000657	0.000797	CcSEcCtD
Ixabepilone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000656	0.000795	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000655	0.000794	CcSEcCtD
Ixabepilone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000653	0.000792	CcSEcCtD
Ixabepilone—Rash—Leflunomide—systemic scleroderma	0.000653	0.000792	CcSEcCtD
Ixabepilone—Dermatitis—Leflunomide—systemic scleroderma	0.000652	0.000791	CcSEcCtD
Ixabepilone—Mental disorder—Prednisone—systemic scleroderma	0.000652	0.00079	CcSEcCtD
Ixabepilone—Nausea—Azathioprine—systemic scleroderma	0.000651	0.00079	CcSEcCtD
Ixabepilone—Headache—Leflunomide—systemic scleroderma	0.000649	0.000787	CcSEcCtD
Ixabepilone—Malnutrition—Prednisone—systemic scleroderma	0.000648	0.000785	CcSEcCtD
Ixabepilone—Asthenia—Lisinopril—systemic scleroderma	0.000638	0.000774	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000638	0.000773	CcSEcCtD
Ixabepilone—Pruritus—Lisinopril—systemic scleroderma	0.00063	0.000763	CcSEcCtD
Ixabepilone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000628	0.000762	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—systemic scleroderma	0.000625	0.000758	CcSEcCtD
Ixabepilone—Rash—Mycophenolic acid—systemic scleroderma	0.000623	0.000755	CcSEcCtD
Ixabepilone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000622	0.000754	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—systemic scleroderma	0.000622	0.000754	CcSEcCtD
Ixabepilone—Headache—Mycophenolic acid—systemic scleroderma	0.000619	0.00075	CcSEcCtD
Ixabepilone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000616	0.000747	CcSEcCtD
Ixabepilone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000616	0.000747	CcSEcCtD
Ixabepilone—Nausea—Leflunomide—systemic scleroderma	0.000615	0.000746	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000614	0.000744	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—systemic scleroderma	0.000609	0.000739	CcSEcCtD
Ixabepilone—Diarrhoea—Lisinopril—systemic scleroderma	0.000609	0.000738	CcSEcCtD
Ixabepilone—Anaemia—Prednisone—systemic scleroderma	0.000598	0.000726	CcSEcCtD
Ixabepilone—Dizziness—Lisinopril—systemic scleroderma	0.000588	0.000713	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000588	0.000713	CcSEcCtD
Ixabepilone—Nausea—Mycophenolic acid—systemic scleroderma	0.000587	0.000711	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—systemic scleroderma	0.000581	0.000704	CcSEcCtD
Ixabepilone—Syncope—Prednisone—systemic scleroderma	0.000581	0.000704	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000577	0.000699	CcSEcCtD
Ixabepilone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000696	CcSEcCtD
Ixabepilone—Loss of consciousness—Prednisone—systemic scleroderma	0.000569	0.00069	CcSEcCtD
Ixabepilone—Vomiting—Lisinopril—systemic scleroderma	0.000566	0.000686	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—systemic scleroderma	0.000564	0.000684	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—systemic scleroderma	0.000561	0.000681	CcSEcCtD
Ixabepilone—Rash—Lisinopril—systemic scleroderma	0.000561	0.00068	CcSEcCtD
Ixabepilone—Dermatitis—Lisinopril—systemic scleroderma	0.000561	0.00068	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00056	0.000679	CcSEcCtD
Ixabepilone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000678	CcSEcCtD
Ixabepilone—Chills—Methotrexate—systemic scleroderma	0.000558	0.000676	CcSEcCtD
Ixabepilone—Headache—Lisinopril—systemic scleroderma	0.000557	0.000676	CcSEcCtD
Ixabepilone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000552	0.000669	CcSEcCtD
Ixabepilone—Myalgia—Prednisone—systemic scleroderma	0.000551	0.000668	CcSEcCtD
Ixabepilone—Arthralgia—Prednisone—systemic scleroderma	0.000551	0.000668	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—systemic scleroderma	0.000549	0.000666	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000547	0.000664	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—systemic scleroderma	0.000545	0.00066	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—systemic scleroderma	0.000541	0.000656	CcSEcCtD
Ixabepilone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000533	0.000647	CcSEcCtD
Ixabepilone—Nausea—Lisinopril—systemic scleroderma	0.000529	0.000641	CcSEcCtD
Ixabepilone—Oedema—Prednisone—systemic scleroderma	0.000528	0.000641	CcSEcCtD
Ixabepilone—Infection—Prednisone—systemic scleroderma	0.000525	0.000637	CcSEcCtD
Ixabepilone—Shock—Prednisone—systemic scleroderma	0.00052	0.00063	CcSEcCtD
Ixabepilone—Nervous system disorder—Prednisone—systemic scleroderma	0.000518	0.000628	CcSEcCtD
Ixabepilone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000625	CcSEcCtD
Ixabepilone—Skin disorder—Prednisone—systemic scleroderma	0.000513	0.000622	CcSEcCtD
Ixabepilone—Anorexia—Prednisone—systemic scleroderma	0.000504	0.000611	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—systemic scleroderma	0.0005	0.000606	CcSEcCtD
Ixabepilone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000496	0.000601	CcSEcCtD
Ixabepilone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000596	CcSEcCtD
Ixabepilone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000491	0.000595	CcSEcCtD
Ixabepilone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000592	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—systemic scleroderma	0.000484	0.000587	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000481	0.000584	CcSEcCtD
Ixabepilone—Insomnia—Prednisone—systemic scleroderma	0.000478	0.000579	CcSEcCtD
Ixabepilone—Paraesthesia—Prednisone—systemic scleroderma	0.000475	0.000575	CcSEcCtD
Ixabepilone—Cough—Methotrexate—systemic scleroderma	0.000472	0.000573	CcSEcCtD
Ixabepilone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000561	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—systemic scleroderma	0.000461	0.000559	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—systemic scleroderma	0.000461	0.000559	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—systemic scleroderma	0.000461	0.000559	CcSEcCtD
Ixabepilone—Decreased appetite—Prednisone—systemic scleroderma	0.000459	0.000557	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000458	0.000555	CcSEcCtD
Ixabepilone—Fatigue—Prednisone—systemic scleroderma	0.000456	0.000552	CcSEcCtD
Ixabepilone—Constipation—Prednisone—systemic scleroderma	0.000452	0.000548	CcSEcCtD
Ixabepilone—Infection—Methotrexate—systemic scleroderma	0.000439	0.000532	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000433	0.000525	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000432	0.000524	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000432	0.000524	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—systemic scleroderma	0.000429	0.00052	CcSEcCtD
Ixabepilone—Anorexia—Methotrexate—systemic scleroderma	0.000421	0.00051	CcSEcCtD
Ixabepilone—Body temperature increased—Prednisone—systemic scleroderma	0.000418	0.000506	CcSEcCtD
Ixabepilone—Abdominal pain—Prednisone—systemic scleroderma	0.000418	0.000506	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—systemic scleroderma	0.000413	0.0005	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000402	0.000488	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—systemic scleroderma	0.000399	0.000484	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—systemic scleroderma	0.000397	0.000481	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—systemic scleroderma	0.000394	0.000477	CcSEcCtD
Ixabepilone—Hypersensitivity—Prednisone—systemic scleroderma	0.000389	0.000472	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—systemic scleroderma	0.000384	0.000465	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000381	0.000462	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—systemic scleroderma	0.000381	0.000462	CcSEcCtD
Ixabepilone—Asthenia—Prednisone—systemic scleroderma	0.000379	0.00046	CcSEcCtD
Ixabepilone—Pain—Methotrexate—systemic scleroderma	0.000378	0.000458	CcSEcCtD
Ixabepilone—Pruritus—Prednisone—systemic scleroderma	0.000374	0.000453	CcSEcCtD
Ixabepilone—Diarrhoea—Prednisone—systemic scleroderma	0.000362	0.000438	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000361	0.000438	CcSEcCtD
Ixabepilone—Dizziness—Prednisone—systemic scleroderma	0.000349	0.000424	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—systemic scleroderma	0.000349	0.000423	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—systemic scleroderma	0.000349	0.000423	CcSEcCtD
Ixabepilone—Vomiting—Prednisone—systemic scleroderma	0.000336	0.000407	CcSEcCtD
Ixabepilone—Rash—Prednisone—systemic scleroderma	0.000333	0.000404	CcSEcCtD
Ixabepilone—Dermatitis—Prednisone—systemic scleroderma	0.000333	0.000404	CcSEcCtD
Ixabepilone—Headache—Prednisone—systemic scleroderma	0.000331	0.000401	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000325	0.000395	CcSEcCtD
Ixabepilone—Asthenia—Methotrexate—systemic scleroderma	0.000317	0.000384	CcSEcCtD
Ixabepilone—Nausea—Prednisone—systemic scleroderma	0.000314	0.000381	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—systemic scleroderma	0.000312	0.000379	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—systemic scleroderma	0.000302	0.000366	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—systemic scleroderma	0.000292	0.000354	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—systemic scleroderma	0.000281	0.00034	CcSEcCtD
Ixabepilone—Rash—Methotrexate—systemic scleroderma	0.000278	0.000338	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—systemic scleroderma	0.000278	0.000337	CcSEcCtD
Ixabepilone—Headache—Methotrexate—systemic scleroderma	0.000277	0.000335	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—systemic scleroderma	0.000262	0.000318	CcSEcCtD
